Cliquez ici pour lire en français
In laboratories, identifying bacteria and fungi is a critical step for public health, product quality and environmental protection. Yet conventional methods often take several days to deliver a usable result. A new wave of technology aims to shrink that wait, and one of the entrepreneurs betting on it is Mohamed M. Diallo, a Mauritanian biochemist now based in Canada. As CEO of Bioeureka, a startup he founded in 2022, he is using artificial intelligence and automation to modernize microbiological analysis and help detect disease-causing microorganisms earlier.
Artificial intelligence at the heart of microbiology testing 🧬
Bioeureka’s pitch is simple: reliable results in a fraction of the time traditional processes demand. The company’s flagship platform, AIMO, uses AI to analyze microscope images. According to We Are Tech Africa, which reported the story, it can reportedly identify bacteria or fungi and deliver results in just a few minutes, where traditional methods take several days. Those timings come without details on how they were measured, so they remain claims until independent evaluations back them up. If they hold, they would show how AI is gradually reshaping lab routines by cutting the waiting time that comes with microbiological testing.
When automation boosts lab efficiency 🚀
Bioeureka’s innovation goes beyond image analysis. The company also offers MicroSelect, a solution meant to speed up the initial culture of target microorganisms, meaning the step where they are grown in the lab before being identified. Together, the two tools create a more automated working environment. Repetitive tasks usually handled by lab technicians could be simplified, which would let labs work more efficiently while speeding up checks. The approach has applications wherever precision and responsiveness matter. Agri-food, scientific research and higher education could all benefit from tools designed to improve quality control of water, soil and air.
A path through science, entrepreneurship and innovation 🔬
Beyond Bioeureka, Diallo also runs Attani, a joint-venture company (a « société en participation » under Quebec-style French business law) focused on creating and managing innovative tech businesses. The dual role reflects an effort to bring scientific expertise and entrepreneurship together.
His academic path was built in Canada: a bachelor’s degree in biochemistry and molecular biology from the University of Ottawa in 2017, followed by a university technology diploma in biological engineering in 2020. Professionally, he started in marketing in Quebec in 2013, then ran Projets Outaouais, an event marketing company, from 2018. Between 2021 and 2023, he worked as a quality manager at Hexo Corp, a consumer goods company.
Today, his work points to the growing role of AI in the life sciences. By combining image analysis, automation and microbiology, Bioeureka aims to make health and quality checks faster and more efficient. The open question is whether those promises will hold up at scale. Diallo’s story, a Mauritanian entrepreneur building his company in Canada, also raises the question of what such tools could mean for laboratories across Africa.
Can AI become an essential tool for speeding up lab analysis and strengthening public health at scale, including in African labs? Tell us in the comments.
📱 Get our latest updates every day on WhatsApp, directly in the “Updates” tab by subscribing to our channel here ➡️ TechGriot WhatsApp Channel Link 😉
